Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Tenascins and inflammation in disorders of the nervous system.
Personality characteristics in MS patients: The role of avoidant personality.
Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Lipid microarrays identify key mediators of autoimmune brain inflammation.
Acute transverse myelitis: an unusual complication of typhoid fever.
Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis.
"People power" or "pester power"? YouTube as a forum for the generation of evidence and patient advocacy.
Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial.
MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory.
Patients' experiences of health and social care in long-term neurological conditions in England: a cross-sectional survey.
The changing clinical course of multiple sclerosis: A matter of grey matter.
Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.
Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.
Fingolimod (Gilenya) licence extended
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Remyelination: The True Regeneration of the Central Nervous System.
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit.
Cognitive reserve and symptom experience in multiple sclerosis: A buffer to disability progression over time?
Early development of anti-natalizumab antibodies in MS patients.
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort.
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.

Pages